These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2516891)
1. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients. Sundal E; Kaeser U Nephrol Dial Transplant; 1989; 4(11):979-87. PubMed ID: 2516891 [TBL] [Abstract][Full Text] [Related]
2. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. Frenken LA; Verberckmoes R; Michielsen P; Koene RA Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609 [TBL] [Abstract][Full Text] [Related]
4. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis. Van Damme-Lombaerts R; Broyer M; Businger J; Baldauf C; Stocker H Pediatr Nephrol; 1994 Jun; 8(3):338-42. PubMed ID: 7917862 [TBL] [Abstract][Full Text] [Related]
5. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile. Sundal E; Businger J; Kappeler A Nephrol Dial Transplant; 1991; 6(12):955-65. PubMed ID: 1798595 [TBL] [Abstract][Full Text] [Related]
6. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration]. Zehnder C; Blumberg A Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110 [TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis]. Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185 [TBL] [Abstract][Full Text] [Related]
8. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323 [TBL] [Abstract][Full Text] [Related]
9. Treatment of anaemia in haemodialysis patients with recombinant erythropoietin. Winearls CG Nephron; 1989; 51 Suppl 1():26-8. PubMed ID: 2915779 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group. Kulzer P; Schaefer RM; Krahn R; Schaefer L; Heidland A Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure. Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357 [TBL] [Abstract][Full Text] [Related]
12. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin. Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886 [TBL] [Abstract][Full Text] [Related]
13. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency]. Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin]. Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424 [TBL] [Abstract][Full Text] [Related]
15. Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long term haemodialysis. Sobh MA; el-Tantawy AE; Said E; Atta MG; Refaie A; Nagati M; Ghoneim M Scand J Urol Nephrol; 1992; 26(1):65-9. PubMed ID: 1631509 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients. Nephron; 1992; 61(4):399-403. PubMed ID: 1501735 [TBL] [Abstract][Full Text] [Related]
17. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous. Hörl WH Acta Haematol; 1992; 87 Suppl 1():16-9. PubMed ID: 1574961 [TBL] [Abstract][Full Text] [Related]
18. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis. Li WY; Chu TS; Huang JW; Wu MS; Wu KD J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience]. de Sousa FT; Prata MM; Barbas JV; dos Santos JP Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856 [TBL] [Abstract][Full Text] [Related]
20. Anaemia and its response to treatment with recombinant human erythropoietin in chronic kidney disease patients. Abdu A; Arogundade F; Adamu B; Dutse AI; Sanusi A; Sani MU; Mijinyawa MS; Akinsola A; Borodo MM West Afr J Med; 2009; 28(5):295-9. PubMed ID: 20383832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]